Laparoscopic Adrenalectomy by Craig N Parnaby & Patrick J O’Dwyer
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
8 
Laparoscopic Adrenalectomy 
Craig N Parnaby and Patrick J O’Dwyer 
University of Glasgow, Glasgow 
United Kingdom 
1. Introduction 
Laparoscopic adrenalectomy (LA) was first described by Gagner et al in 1992 (Gagner et al., 
1992). Since this time LA has become the procedure of choice for most adrenal pathologies. 
Multiple case-control studies have consistently demonstrated the benefits of LA compared 
to open adrenalectomy (OA) in terms of blood loss, analgesic requirments, postoperative 
complications, hospital stay and earlier return to normal activity. 
2. Clinical presentation 
Clinical presentation can often be non-specific or the patient can present after incidental 
adrenal gland imaging. 
2.1 Conn’s syndrome 
Conn’s syndrome is an aldosterone producing adenoma. The symptoms and signs are non-
specific and include hypertension and hypokalaemia. 
2.2 Cushing’s syndrome 
Symptoms and signs are related to excess cortisol production. These include: truncal 
obesity, decreased libido, thin skin, hypertension, hirsutism, depression, easy bruising, 
glucose intolerance and general weakness. 
2.3 Phaeochromocytoma 
A phaeochromocytoma is usually associated with excess production of catecholamines. The 
tumour can be suspected when a patient presents with: episodic episodes of headaches, 
sweating and palpitations with poorly controlled persistent or intermittent hypertension. 
2.4 Incidentaloma 
Adrenal incidentaloma is an adrenal tumour (≥1cm) discovered on an imaging study for 
other unrelated pathologies. Over the last one and a half decades incidental adrenal gland 
imaging is increasingly performed as computed tomography for other abdominal 
pathologies has become common. This has led to an increase in patients with an incidental 
adrenal tumour referred for surgical and endocrine assessment (Saunders et al., 2004). 
Presently between 4-6% of the imaged population have incidentalomas (Bovio et al., 2006; 
Kloos et al., 1995). Almost all these lesions will be benign in a patient without a known 
history of cancer (Song et al., 2007; Young, 2000). 
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2.5 Adrenal metastasis 
Adrenal metastasis should be considered in any patient with known extraadrenal 
malignancy and an isolated adrenal lesion >2cm or an adrenal mass increasing in size on 
serial imaging (Bonnet et al.,2008). 
3. Assessment of adrenal tumours 
Adrenal tumours are characterised by radiological and hormonal assessment. 
3.1 Hormonal assessment 
All adrenal tumours require a hormone evaluation. The hormone studies are performed to 
check for: phaeochromocytoma, hypercortisolism and hyperaldosteronism. However, there 
is no consensus regarding the best hormone diagnostic approach. 
A suggested approach would be:   
1. A phaeochromocytoma screen included a 24 hour urine collection for catecholamines 
(norepinephrine, epinephrine and dopamine) and metabolites (metanephrine, 
normetanephrine, vanillylmandelic acid).  
2. Hypercortisolism assessment included an overnight dexamethasone suppression test. If 
positive a suppressed morning plasma ACTH and DHEAS level can be used to support 
the diagnosis (Nieman, 2010).  
3. Hyperaldosteronism should be excluded in hypertensive patients. A screen included 
urea and electrolytes, plasma aldosterone-to-renin ratio. Adrenal vein sampling can be 
used for patients with suspected Conn’s syndrome when imaging does not demonstrate 
an obvious adenoma. 
3.2 Radiological assessment 
The main modalities of choice in the evaluation of an adrenal tumour are computed 
tomography (CT) or magnetic resonance imaging (MRI). Most investigators use CT as the 
initial modality of choice as it is readily available and cheaper.  Occasionally when CT or 
MRI studies are inconclusive patients are referred for combined positron emission 
tomography and computed tomography (PET-CT). 
Adrenal tumours can be characterized using imaging alone. Characterisation of the adrenal 
tumour depends on a number of factors which include: morphology, perfusion differences 
and intracellular lipid concentration (Boland et al., 2008). 
Morphology appearances which may suggest malignancy include: increased size, large 
necrotic areas, increased heterogeneity, irregular borders and local invasion. Available data 
suggests, at a size threshold of ≥4cm the likelihood of malignancy doubles and is more than 
ninefold higher for tumours ≥8cm (Sturgeon et al., 2006). 
Lipid sensitive imaging by CT or MRI exploit the fact that most adenomas contain abundant 
intracellular fat where as almost all malignant lesions do not (Korobkin et al., 1996). It has 
been reported an unenhanced CT densitometry technique can effectively differentiate many 
adrenal adenomas from malignant adenomas. Figure 3.1 shows a typical adrenal adenoma 
from an unenhanced CT. 
If the CT attenuation threshold is set at 10 hounsfield units the sensitivity and specificity for 
characterising adenomas versus non-adenomas has been reported 71% and 98% respectively 
(Boland et al.,1998). This method has limitations which include: up to 30 % of adenomas are 
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lipid poor and most CT scans for other pathologies are contrast enhanced (Boland et al., 
2008). Therefore, using attenuation values in these cases would be considered indeterminate 
or difficult to interpret.  
More recently studies have reported improved results using CT perfusion washout scans or 
chemical shift MR imaging. For CT, an initial non-contrast or contrast enhanced scan is 
performed followed by a contrast enhanced examination after a variable delay (often 15 
minutes). Benign lesions typically demonstrate more than 50% washout. A threshold 
enhancement washout value is then calculated. Chemical shift MR imaging utilises the 
different resonant frequencies of fat and water protons. Benign lesions typically show signal 
intensity decrease when compared with in-phase images. From the available data, CT 
perfusion washout scan appears to offer the highest sensitivity and specificity for adrenal 
adenoma characterization (Park et al., 2007). 
 
 
Fig. 3.1 Unenhanced CT of a left adrenal adenoma (arrow) 
PET-CT allows adrenal lesion morphology and metabolic activity to be coregistered on the 
same image. This would allow a more accurate anatomic localization of any PET 
abnormalities. In current practice patients would only be referred for PET-CT rarely if CT or 
MR results are inconclusive (Boland et al., 2008). 
123 I-MIBG is concentrated in catecholamine storage vesicles. A meta-iodobenzylguanidine 
(MIBG) scan can help identify phaeochromocytoma, extra-adrenal phaeochromocytoma and 
metastatic deposits from the phaeochromocytoma. 
Despite the above techniques, the only reliable imaging findings to differentiate between 
malignant and benign adrenal tumours remain the presence of regional invasion or 
metastatic disease. 
3.3 Adrenal fine-needle aspiration (FNA) 
Ultrasound or computed tomography guided FNA is unhelpful to distinguish between 
benign and malignant adrenal tumours due to the high false negative rate (Sasano et 
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al.,1995). The only potential use of FNA is to help diagnose metastasis when adrenal 
resection is not planned and detection would alter patient management (Lee et al., 1998). 
3.4 Suggested hormonal and radiological approach to an adrenal tumour 
 
History and physical examination
Hormonal testing
•Overnight dexamethasone suppression test
•24hour urinary catecholamines
•ARR (if hypertensive)
Confirmatory testing
Benign appearance
<4 cm
<10 HU (non contrast)
Contrast washout >50%
Consider:
Surgery
FNA if ? metastatic disease
Close follow up
Confirmation of autonomous 
secretion of cortisol, 
aldosterone or 
catecholamines
Consider:
Surgery
Imaging phenotype
Positive 
results
Negative 
results
Lack of autonomous 
hormone secretion
Consider:
Repeat imaging (6/12 
months)
?Repeat hormonal testing
Surgery if >4cm
Suspicious appearance
> 4cm
> 10 HU
Contrast washout < 50%
Growth >1cm
Autonomous 
hormone 
secretion
 
Fig. 3.2 gives a suggested algorithm for the evaluation of an adrenal tumour 
4. Indication for adrenalectomy 
Adrenalectomy is indicated for all hormonally active adrenal lesions, suspicion of adrenal 
malignancy on imaging (size ≥4cm, local invasion, tumour heterogeneity, high attenuation 
and irregular tumour margins) and isolated adrenal metastases. Resection of non 
functioning adrenal tumours <4cm was indicated for patients with evidence of tumour 
growth on serial radiological imaging.  
Management of a non functioning adrenal lesion remains debatable. All authors advocate 
resection of large ≥6cm non functional adrenal tumours due to the increased risk of 
malignancy. No prospective controlled studies exist for the role of adrenalectomy for 
adrenal masses of 3-6 cm. Different authors have advocated size tumour thresholds of 3,4,5 
and 6cm for resection of non functioning adrenal tumours (Duh, 2002; Thompson et al., 
2003; Eldeiry & Garber, 2008). Sturgeon et al characterized the relationship between tumour 
size and malignancy risk compared the National Cancer Institute’s Surveillance, 
Epidemiology, and End Results (SEER) database for adrenocortical carcinoma with their 
own experience with benign adrenal cortical adenomas from a similar time period. From the 
SEER database 457 adrenal cortical carcinomas were identified (376 had size data) and 47 
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patients from their own series with benign adrenal cortical adenomas. The authors found a 
tumour threshold of 4cm has a sensitivity and specificity of 96% and 52% for malignancy 
versus 90% and 80% for a tumour threshold of 6cm. The authors advocated that all tumours 
≥4cm should be surgical resected (Sturgeon et al., 2006). 
4.1 Indications for laparoscopic adrenalectomy 
Within a specialised centre, we feel the only contraindication to laparoscopy were large 
locally invasive adrenal carcinoma or the requirement of an additional open operation. 
5. Perioperative management 
5.1 Bilateral adrenalectomy 
Bilateral adrenalectomy can be indicated following relapse after pituitary surgery, bilateral 
adrenal hyperplasia or hereditary phaeochromocytoma. Perioperative intravenous 
hydrocortisone is required to prevent acute adrenal insufficiency. When oral intake has been 
established lifelong oral steroids are required. Increased doses are required at times of stress 
(eg trauma, infection). 
5.2 Autonomous cortisol secretion 
For patients with autonomous cortisol secretion after hormonal testing a perioperative 
‘stress dose’ of hydrocortisone is recommended. A post operative in-patient short 
SYNACTHEN test would follow. If the test indicates adrenal insufficiency (low level of 
stimulated cortisol) steroid replacement should continue as this indicates hypothalamic-
pituitary-adrenal (HPA) axis suppression. Patients are then reviewed as an out-patient to 
test for HPA axis recovery. If the test indicates adequate cortisol response (functioning HPA 
axis) steroid replacement therapy can stop. 
5.3 Phaeochromocytoma 
The perioperative medical management of patients with phaeochromocytomas is essential 
to reduce the effects of circulating catecholamines (Plouin et al., 2001; Kinney et al., 2000). 
These can include severe hypertension (systolic blood pressure >200mmHg), tachycardia, 
arrhythmias and death. Immediate surgery is rarely essential. 
Medical management aims to control blood pressure, heart rate and arrhythmias. Traditional 
preoperative regimens have included phenoxybenzamine (a long-acting non-selective alpha 
blocker) and propanolol (beta blocker) (Ross et al., 1967). Other agents have been used 
effectively including selective alpha blockers and calcium channel antagonists (Prys-Roberts & 
Farndon., 2002; Lebuffe et al., 2005). No randomised trial exists comparing the traditional 
regimen with other medical managements. Currently, the most effective perioperative drug 
regimen for patients undergoing phaeochromocytoma resection is unknown. 
Despite preoperative medical management, intraoperative tumour manipulation or 
introduction of pneumoperitoneum (laparoscopic adrenalectomy) may cause severe 
haemodynamic responses requiring further treatment with short acting alpha blockers  
(eg phentolamine) or short acting beta blockers (eg labetalol) (Joris et al., 1999; Tauzin-Fin et 
al., 2004). 
The current regimen we use at the Western Infirmary, Glasgow, is as follows. At initial 
endocrine assessment, all patients with a suspected phaeochromocytoma received oral 
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phenoxybenzamine as the primary alpha blocker (range 10-60mg/day). This was titrated to 
achieve a blood pressure measurement <160/90 mmHg. Patients were not routinely beta-
blocked in the preoperative period. Hypertension was controlled in all phaeochromocytoma 
patients prior to elective resection.  
All patients in the phaeochromocytoma group received an infusion of phenoxybenzamine 
(1mg kg-1, a non selective long acting alpha blocker) the day before LA. Oral 
phenoxybenzamine was discontinued the day before theatre. 
Arterial blood pressure is monitored using a radial arterial line. During surgery, episodes of 
hypertension (SBP>180mmHg) were treated with intravenous phentolamine (boluses 1 to 
2mg) and/or labetalol (boluses 5 to 10mg). Tachycardia was treated with intravenous 
labetalol (boluses 5 to 10mg). Hypotension was treated with fluid boluses (crystalloid or 
colloid) and/or an intravenous vasopressor (metaraminol). 
There is some concern that the persistent α-adrenoceptor blockade caused by 
phenoxybenzamine after resection can cause persistent hypotension resistant to adrenergic 
arteriolar constrictors and large volumes of intravascular fluid (Prys-Roberts et al., 2002). 
This has not been realised in our series. From January 1999 – January 2009, there were 42 
consecutive LA performed for phaeochromocytoma. No patient experienced persistent 
hypotension (systolic blood pressure <80mmHg >10 minutes) in the recovery room period.  
6. Laparoscopic adrenalectomy 
Laparoscopic adrenalectomy was first described by Gagner et al in 1992 (Gagner et al., 1992). 
They described a successful anterior transabdominal approach in 3 patients (Cushing’s 
syndrome, Cushing’s disease and a phaeochromocytoma). The authors felt that LA may 
reduce morbidity, reduce analgesic requirements and reduce post operative stay when 
compared to open adrenalectomy (OA). 
Since this time, multiple case-control studies have consistently demonstrated the benefits of 
LA compared OA in terms of blood loss, analgesic requirements, post operative complications, 
hospital stay and earlier return to normal activity for a variety of adrenal gland pathologies. 
Table 6.1 gives an overview of outcomes for studies comparing LA versus OA. 
Despite the lack of Level 1 evidence comparing LA with OA, it seems unlikely randomized 
controlled trials will be performed. This is primarily due to the benefits consistently 
demonstrated in favour of LA.   
Therefore, LA has become the procedure of choice for most adrenal gland pathologies in 
high-volume centres.  
6.1 Laparoscopic operative technique 
Laparoscopic approaches to the adrenal gland include the lateral transabdominal approach, 
the retroperitoneal approach or the anterior transabdominal approach. 
The lateral transabdominal approach is the most popular approach in published case series. 
Reasons include: easiest to learn due to presence of an increased number of anatomical 
landmarks compared to the retroperitoneal approach and the ability to perform large 
adrenal tumour (≥6cm) resection.  
The retroperitoneal approach was first described in 1995 (Mercan et al., 1995) and 
subsequent series have since reported a safety and efficacy comparable to other laparoscopic 
approaches (Hanssen et al., 2006; Bonjer et al.,2000; Walz et al., 2006). Potential drawbacks to 
this approach include lack of familiarity amongst most general surgeons, limited working 
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*Values are mean. LA, laparoscopic adrenalectomy; OA, open adrenalectomy;  
PCA, patient controlled analgesia;n.a., data not available 
Table 6.1. Outcomes for laparoscopic adrenalectomy versus open adrenalectomy  
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space and the unsuitability for resection of large adrenal tumours (≥6cm). Potential 
advantages include: avoidance of the peritoneal cavity in patients with previous upper 
gastrointestinal surgery and no need to change position in bilateral adrenalectomy (if prone 
jackknife position used). From available studies, patient outcome remains similar compared 
to the lateral transabdominal approach for small-medium sized tumours. 
The anterior transabdominal approach is practised infrequently and therefore the evidence 
favouring this approach is scarce. The main reason for its unpopularity is the increased 
dissection, adjacent structure retraction difficulties and longer operating times compared to 
other procedures. 
In summary, the lateral transabdominal approach is favoured by most surgeons (including 
the current authors) followed by the retroperitoneal approach. Both techniques will be 
described in detail.  
6.1.1 Lateral transabdominal laparoscopic adrenalectomy 
Patient positioning 
The patient placed is in the lateral decubitus position with the operative side up. The table is 
broken to increase the space between the costal margin and iliac crest. 
Left side 
Step 1. Port placement  
The port placements are illustrated in Figure 6.1. The middle port (10mm) is for a 30° camera 
and inserted using an open technique at a point just lateral to the rectus at the level of the 
umbilicus (a veress needle technique is an acceptable alternative). Two instrument ports 
(5mm, 5mm) are inserted under direct vision. One 5mm port is inserted parallel to the costal 
margin in the mid-clavicular line. The other 5mm port is inserted under the eleventh rib in the 
mid-axillary line. A further 5mm port is occasionally required to assist with splenic retraction. 
 
 
Camera port 
(10mm) 
Instrument 
port (5mm) 
Instrument 
port (5mm) 
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Step 2. Splenic flexure and spleen mobilisation 
We use ultrasonic dissection to mobilise the splenic flexure of the colon and the lienorenal 
ligament of the spleen. The colon can then be displaced inferiorly and the spleen displaced 
medially (Figure 6.2). This allows access to the superior pole of the kidney and the adrenal 
gland. 
 
 
Step 3. Adrenal vein identification and division 
Gerota’s fascia is then opened to expose the periadrenal fat. Dissection starts at the infero-
medial aspect to allow early visualisation of the left renal and then the left adrenal vein 
(Figure 6.3). The adrenal vein is then divided between clips. Care is taken to ensure there is 
no duplicate main adrenal vein. 
 
 
 
 
Left adrenal vein 
Left adrenal gland 
Clip applicator 
Spleen 
Adrenal gland 
Lienorenal ligament 
Kidney 
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Step 4. Adrenal gland mobilisation 
Avoid grasping the adrenal gland directly as it is fragile and will tear. The adrenal gland 
together with its surrounding fat are mobilised using ultrasonic dissection from its superior, 
lateral and posterior attachments. Multiple small adrenal arteries and veins will be 
encountered and these can all usually be divided using the harmonic scalpel. 
Step 5. Adrenal gland removal 
The adrenal gland is then removed via the camera port using an impermeable retrieval bag. 
The wound may require extension to allow retrieval. 
Right side 
Step 1. Port placement 
The port placements are illustrated in Figure 6.4. The camera port (10mm) is inserted just 
lateral to the rectus at the level of the umbilicus (30° laparoscope). Two 5mm instrument 
ports are placed as for the left side and a third is placed in the right iliac fossa. The most 
medial port is used to retract the right liver lobe. We have found an atraumatic grasper 
offers reasonable retraction. 
 
 
 
 
 
 
 
 
 
 
Step 2. Right liver lobe mobilisation 
The right lobe of liver is mobilised from its lateral and posterior attachments and retracted 
(Figure 6.5). This allows access to the adrenal gland and inferior vena cava. 
Instrument port 
(5mm) 
Liver retractor 
Camera port (10mm) 
Instrument port 
(5mm) 
Instrument port 
(5mm) 
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Step 3. Inferior vena cava and right adrenal vein 
The peritoneum overlying the lateral edge of the inferior vena cava is divided carefully. The 
lateral border of the inferior vena cava is dissected from the inferior part of the liver to the 
origin of the right renal vein. The short main adrenal vein will be located between these 
points. After careful dissection the adrenal vein is divided between clips (Figure 6.6). Care 
should be taken as occasionally there can be a duplicate main adrenal vein. 
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Step 4. Adrenal gland mobilisation 
The adrenal gland together with its surrounding fat is then completely mobilised using 
ultrasonic dissection (Figure 6.7). 
 
 
 
Step 5. Step 5 Adrenal gland removal 
The adrenal gland and tumour is removed in the same manner as for left adrenalectomy. 
6.1.2 Lateral transabdominal technique modifications for larger adrenal tumours 
The laparoscopic technique was modified for large adrenal tumours. On the right side, 
initial dissection of the inferior vena cava and the adrenal vein is often impossible due to 
tumour size. We like other authors (Henry et al.,2002) start dissecting laterally, superiorly 
and inferiorly (often alternating between these sites). This progressive mobilisation then 
allows access to the inferior vena cava and the procedure continues as described above. 
Similarly, on the left, initial adrenal vein dissection may not be possible due to tumour size. 
Primary lateral, superior, inferior dissection and mobilisation allows access to the adrenal 
vein. Often, it is not possible to insert these large tumours into a retrieval bag. In these cases 
a wound protector is inserted and the tumour is removed directly through the wound. 
6.1.3 Retroperitoneal laparoscopic adrenalectomy 
The following operative technique has been described and then developed by Walz and 
colleagues (Barczynski et al.,2007). 
Patient position 
Patient is placed in the prone jackknife position 
Left side 
Step 1. Port placement 
The initial 10-12mm camera port is placed using an open technique just below the 12th rib. 
The retroperitoneum was accessed by digital perforation of Gerota’s fascia. A 30° 
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laparoscope was inserted and the retroperitoneal cavity was bluntly gently enlarged. Two 
5mm ports were inserted, 4-5cm either side of the camera port. The retroperitoneal pressure 
was set at 20-25mmHg. 
Step 2. Creation of a retroperitoneal space 
A large retroperitoneal space is created using blunt dissection with the laparoscope and 
blunt dissectors. The adrenal gland tumour and upper pole of the kidney are identified. 
Step 3. Initial adrenal gland mobilisation 
The upper pole of the kidney is mobilised this allows access to the lower part of the adrenal 
gland. The inferomedial border of the adrenal gland is then carefully mobilised. 
Step 4. Identification and division of main adrenal vein 
The main adrenal vein is located lying below the adrenal gland and medial to the upper 
kidney pole. The adrenal vein is then clipped and divided. 
Step 5. Completion of adrenal gland mobilisation 
The adrenal gland is then fully mobilised using ultrasonic dissection. The final part of the 
operation is to mobilise the adrenal gland off the peritoneum. If the peritoneum is opened, it 
does not require subsequent closure. 
Step 6. Extraction of the adrenal gland 
The adrenal gland is removed through the middle port in an extraction bag. For large 
adrenal tumours the extraction site can be extended.  
Right side 
Step 1. Port placement 
The camera and instrument ports are placed on the right side using the same technique as 
the left side. 
Step 2.  Creation of a retroperitoneal space 
A large retroperitoneal space is created using blunt dissection with the laparoscope and 
blunt dissectors. The adrenal gland tumour and upper pole of the kidney are identified. 
Step 3. Initial adrenal gland mobilisation 
The upper pole of the kidney is mobilised this allows access to the lower part of the adrenal 
gland. The adrenal gland is then mobilised laterally around the top of the adrenal gland and 
continued medially. The adrenal gland arteries were divided by ultrasonic dissection and 
the posterior surface of the inferior vena cava was identified. 
Step 4. Identification and division of main adrenal vein 
The inferior vena cava is carefully demonstrated. The short adrenal vein can be seen 
running postero-laterally. The vein is then clearly identified, clipped and divided. 
Step 5. Completion of adrenal gland mobilisation 
The fatty tissue between the kidney and adrenal gland are separated. The anterior adhesions 
between the adrenal gland and peritoneum are separated allowing completion of the 
mobilisation. 
Step 6. Extraction of the adrenal gland 
The adrenal gland is removed through the middle port in an extraction bag. For large 
adrenal tumours the extraction site can be extended.   
6.1.4 Uncertainty of laparoscopic adrenalectomy for large (≥6cm) potentially 
malignant tumours 
It is uncertain if the resection of large (≥6cm) potentially malignant adrenal tumours is 
appropriate due to concern over incomplete resection and local recurrence. However, an 
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increasing number of series have demonstrated the safety of this approach together with 
low rates of local recurrence. Table 6.2 shows the outcome of studies for the laparoscopic 
removal of large adrenal tumours. 
 
Author LA≥6cm  
over 
Total LA* 
 
No of 
patients 
with 
malignancy
Tumour 
size 
(cm)† 
Conversion
for large 
tumours 
Incomplet
e resection
Local 
recurrence 
Mets Follow-
up† 
(months) 
 (Henry et al., 
2002)  
 
19/233 
(8%) 
 
6 (6) 
 
7 (6-8) 
 
2 
 
0 
 
0 
 
1 
 
35 (17-59) 
(MacGillivray, 
Whalen, 
Malchoff, 
Oppenheim, 
& Shichman, 
2002) 
 
12/60 
(20%) 
 
3 (1) 
 
8 (6-12) 
 
0 
 
0 
 
0 
 
1 
 
24.5 (4-42) 
 (Walz et al., 
2005)  
 
33/429 
(8%) 
 
6 (2) 
 
7.3 (2.1)¶
 
2 
 
n.a. 
 
2 
 
5 
 
n.a. 
 (Palazzo et 
al., 2006)  
 
19/391 
(5%) 
 
3(3) 
 
6.5 (6-8)
 
0 
 
n.a. 
 
1 
 
2 
 
25 (13-46) 
 (Soon et al., 
2008)  
 
16/140 
(11%) 
 
3 (3) 
 
n.a. 
 
4 
 
n.a. 
 
0 
 
1 
 
18 (n.a.) 
 (Ramacciato 
et al., 2008)  
 
20/107Ϯ 
(19%) 
 
4 (2) 
 
8 (7-9) 
 
3 
 
0 
 
0 
 
1 
 
n.a. 
Authors series 
(1999-2009) 
69/176 
(39%) 
20 (10) 8 (6.5-9) 6 0 0 3 41 (22-76) 
* Values in parentheses are percentage of LA for tumours ≥6cm or ≥7cm in the case series 
Ϯ Tumours are 7cm or larger 
° Values in parentheses are numbers of primary adrenal cortical carcinomas 
† Values are median (IQR) unless stated 
¶Value is mean (range)n.a. , data not available 
Table 6.2. Laparoscopic adrenalectomy for large adrenal tumours 
Currently, we feel like other authors, adopting a policy of LA only for tumours <6cm or 
highly selecting those with tumours >6cm would prevent a large number of patients 
receiving the benefits of the laparoscopic approach. Even in the presence of malignancy, 
laparoscopic resection can achieve very favourable oncological outcomes after long-term 
follow-up. The laparoscopic approach gives an excellent view of large tumours and radical 
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resection with a low blood loss can be performed without the need for large abdominal or 
thoracoabdominal incisions in these patients. 
In our series (1999-2009), 69 out of 176 LA were performed for adrenal masses ≥6cm. There 
were six conversions in this group, mainly for local tumour invasion. Post operative stay for 
patients with adrenal tumours ≥6cm was a day longer compared to those <6cm (3 days 
versus 2 days). After a median follow up of 41 months, there has been no clinical or 
radiological evidence of local recurrence in any patient that has had an attempted 
laparoscopic approach. 
6.2 Laparoscopic subtotal adrenalectomy 
Laparoscopic subtotal adrenalectomy has emerged as a feasible option allowing either 
bilateral adrenal medulla resection or partial adrenal cortex resection in patients with a 
single remaining adrenal gland (Hardy & Lennard,2008). Case series have reported the 
procedure is most strongly indicated in patients with bilateral phaeochromocytoma 
(familial) or patients with aldosterone or cortisol producing tumours who have had 
previous contralateral adrenalectomy. This has been shown to preserve endogenous steroid 
production and allow independence from oral steroid therapy in the majority of patients 
(Brauckhoff et al.,2003). 
Selection for subtotal adrenalectomy has generally been performed in small, well 
circumscribed, peripherally located lesions. It remains unclear from the literature, the true 
incidence of this procedure as totality of adrenalectomy practice is rarely reported. Results 
from small studies have reported no incomplete resections or local recurrences (follow-up 
range:3 months – 3 years) (Walz et al.,1998;Kok&Yapp,2002). 
7. Follow-up 
7.1 Phaeochromocytomas 
Follow-up should be performed indefinitely as the phaeochromocytoma can recur. Follow-
up investigations include: urinary catecholamines, CT, MRI and MIBG. 
7.2 Adrenocortical carcinoma 
For functioning adrenocortical carcinomas, hormonal markers should be measured every 3 
months for early detection of tumour recurrence. 
Restage by CT (chest, abdomen) every 3-6 months for at least 5 years. This is because 
recurrent surgical resection is a valid treatment option. 
7.3 Conn’s syndrome 
Following resection, patient is followed up after six weeks. The blood pressure, urea and 
electrolytes and plasma aldosterone-to-renin ratio are checked. If the results are satisfactory 
the patients can often be discharged. 
7.4 Cushing’s syndrome 
For patients with Cushing’s syndrome (ACTH-independent) resolution of cortisol excess is 
checked in the postoperative stay. However, the majority of patients remain on steroids and 
are reviewed in clinic to assess recovery of HPA axis. If this is satisfactory then steroids can 
be stopped. Postoperative imaging is not usually required. 
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8. Conclusions 
Within an experienced centre (consisting of endocrinologists, anaesthetists and surgeons), 
laparoscopic adrenalectomy has become the procedure of choice for the vast majority of 
adrenal pathologies. A large number of case series have consistently demonstrated the 
improved outcomes of LA compared to the open procedure. We feel, the only 
contraindications to LA were locally invasive adrenal mass on CT or MRI or the 
requirement of an additional open surgical procedure. Currently there is no evidence to 
suggest one laparoscopic approach is better than another. However, the lateral 
transabdominal approach is currently recommended for adrenal tumours ≥ 6cm. 
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